Iowa City, IA, United States of America

Roger Gingrich


Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 110(Granted Patents)


Company Filing History:


Years Active: 2000-2008

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Roger Gingrich - Pioneering Bispecific Antibody Inventions

Introduction:

Roger Gingrich, a prolific inventor hailing from Iowa City, IA, has made significant contributions to the field of biopharmaceuticals with his groundbreaking discoveries. With a notable portfolio of two patents, he has demonstrated a unique ability to create innovative solutions for treating B-cell lymphoma and other related conditions.

Latest Patents:

Gingrich's latest patents showcase his expertise in developing humanized antibodies against CD3 and bispecific antibodies effective in targeting malignant B-cells. These inventions not only target specific antigens on malignant B-cells but also offer therapeutic and diagnostic methods for treating these conditions. His work highlights a dedication to improving the efficacy and precision of antibody-based treatments in oncology.

Career Highlights:

Having worked at esteemed companies such as Protein Design Labs, Inc. and PDL BioPharma, Inc., Roger Gingrich has honed his skills in biopharmaceutical research and development. His experience in these organizations has provided him with invaluable insights into the industry, enabling him to push the boundaries of scientific innovation.

Collaborations:

Throughout his career, Gingrich has collaborated with esteemed professionals in the field, including individuals like George J. Weiner and Brian K. Link. These collaborations have not only enriched his research endeavors but have also fostered a culture of shared knowledge and expertise in developing novel biopharmaceutical solutions.

Conclusion:

In conclusion, Roger Gingrich stands as a trailblazing inventor in the realm of biopharmaceuticals, with a proven track record of developing cutting-edge solutions for combating B-cell lymphoma. His innovative patents and collaborative spirit underscore his commitment to advancing the field of oncology and improving patient outcomes. As he continues to push the boundaries of scientific discovery, Gingrich's contributions are sure to leave a lasting impact on the biomedical landscape.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…